Aerie Pharmaceuticals Inc
NASDAQ:AERI
Income Statement
Earnings Waterfall
Aerie Pharmaceuticals Inc
Revenue
|
213.9m
USD
|
Cost of Revenue
|
-23.5m
USD
|
Gross Profit
|
190.4m
USD
|
Operating Expenses
|
-217.1m
USD
|
Operating Income
|
-26.7m
USD
|
Other Expenses
|
-9.8m
USD
|
Net Income
|
-36.6m
USD
|
Income Statement
Aerie Pharmaceuticals Inc
Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
10
+302%
|
24
+149%
|
35
+45%
|
48
+38%
|
60
+23%
|
70
+17%
|
79
+14%
|
82
+3%
|
83
+2%
|
83
+0%
|
86
+3%
|
95
+11%
|
104
+10%
|
194
+86%
|
201
+4%
|
207
+3%
|
214
+3%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(4)
|
(5)
|
(11)
|
(17)
|
(20)
|
(25)
|
(26)
|
(25)
|
(27)
|
(27)
|
(27)
|
(24)
|
(24)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
9
+301%
|
24
+149%
|
34
+44%
|
47
+38%
|
56
+20%
|
65
+16%
|
69
+6%
|
64
-6%
|
63
-3%
|
58
-8%
|
60
+3%
|
70
+17%
|
77
+10%
|
167
+118%
|
174
+4%
|
183
+5%
|
190
+4%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(16)
|
(19)
|
(22)
|
(27)
|
(33)
|
(41)
|
(50)
|
(61)
|
(67)
|
(71)
|
(75)
|
(78)
|
(82)
|
(88)
|
(97)
|
(100)
|
(105)
|
(114)
|
(146)
|
(161)
|
(191)
|
(228)
|
(233)
|
(251)
|
(254)
|
(246)
|
(253)
|
(252)
|
(244)
|
(233)
|
(214)
|
(206)
|
(205)
|
(211)
|
(214)
|
(220)
|
(215)
|
(217)
|
|
Selling, General & Administrative |
(6)
|
(8)
|
(10)
|
(12)
|
(16)
|
(17)
|
(20)
|
(25)
|
(27)
|
(29)
|
(31)
|
(32)
|
(34)
|
(37)
|
(44)
|
(49)
|
(57)
|
(66)
|
(74)
|
(87)
|
(110)
|
(130)
|
(121)
|
(130)
|
(125)
|
(118)
|
(142)
|
(142)
|
(140)
|
(139)
|
(138)
|
(133)
|
(134)
|
(137)
|
(138)
|
(137)
|
(130)
|
(130)
|
|
Research & Development |
(10)
|
(11)
|
(12)
|
(14)
|
(18)
|
(23)
|
(30)
|
(36)
|
(40)
|
(42)
|
(44)
|
(45)
|
(48)
|
(51)
|
(52)
|
(51)
|
(48)
|
(48)
|
(72)
|
(74)
|
(82)
|
(98)
|
(86)
|
(91)
|
(94)
|
(87)
|
(91)
|
(93)
|
(92)
|
(86)
|
(74)
|
(73)
|
(71)
|
(74)
|
(76)
|
(83)
|
(85)
|
(88)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(27)
|
(30)
|
(35)
|
(40)
|
(19)
|
(17)
|
(12)
|
(7)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(16)
N/A
|
(19)
-18%
|
(22)
-18%
|
(27)
-20%
|
(33)
-25%
|
(41)
-22%
|
(50)
-23%
|
(61)
-21%
|
(67)
-10%
|
(71)
-6%
|
(75)
-6%
|
(78)
-3%
|
(82)
-6%
|
(88)
-7%
|
(97)
-10%
|
(100)
-3%
|
(105)
-5%
|
(114)
-8%
|
(146)
-28%
|
(161)
-11%
|
(189)
-17%
|
(218)
-15%
|
(210)
+4%
|
(217)
-4%
|
(208)
+4%
|
(189)
+9%
|
(188)
+1%
|
(183)
+2%
|
(180)
+2%
|
(170)
+5%
|
(156)
+8%
|
(146)
+6%
|
(135)
+8%
|
(134)
+1%
|
(46)
+65%
|
(46)
+1%
|
(32)
+29%
|
(27)
+18%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(3)
|
(7)
|
(8)
|
(7)
|
(6)
|
(1)
|
(0)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
0
|
0
|
1
|
1
|
(1)
|
(7)
|
(12)
|
(18)
|
(23)
|
(23)
|
(24)
|
(26)
|
(27)
|
(28)
|
(29)
|
(23)
|
(18)
|
(12)
|
|
Total Other Income |
1
|
1
|
(1)
|
(0)
|
(0)
|
(0)
|
2
|
3
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
(24)
|
(24)
|
(23)
|
(24)
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
|
Pre-Tax Income |
(17)
N/A
|
(24)
-41%
|
(31)
-28%
|
(34)
-9%
|
(40)
-16%
|
(42)
-6%
|
(48)
-15%
|
(59)
-22%
|
(66)
-12%
|
(70)
-7%
|
(74)
-6%
|
(80)
-7%
|
(84)
-6%
|
(90)
-7%
|
(99)
-10%
|
(102)
-3%
|
(107)
-5%
|
(116)
-8%
|
(147)
-27%
|
(162)
-10%
|
(188)
-16%
|
(242)
-28%
|
(233)
+4%
|
(240)
-3%
|
(232)
+3%
|
(196)
+16%
|
(200)
-2%
|
(201)
-1%
|
(202)
-1%
|
(192)
+5%
|
(178)
+7%
|
(171)
+4%
|
(161)
+6%
|
(161)
+0%
|
(74)
+54%
|
(67)
+9%
|
(48)
+29%
|
(35)
+27%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(5)
|
(5)
|
(5)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Income from Continuing Operations |
(17)
|
(24)
|
(31)
|
(34)
|
(40)
|
(42)
|
(48)
|
(59)
|
(66)
|
(70)
|
(74)
|
(80)
|
(84)
|
(90)
|
(99)
|
(102)
|
(107)
|
(116)
|
(145)
|
(160)
|
(187)
|
(240)
|
(233)
|
(240)
|
(232)
|
(196)
|
(200)
|
(201)
|
(202)
|
(192)
|
(183)
|
(176)
|
(166)
|
(166)
|
(75)
|
(69)
|
(49)
|
(37)
|
|
Net Income (Common) |
(17)
N/A
|
(24)
-41%
|
(31)
-28%
|
(34)
-9%
|
(40)
-16%
|
(42)
-6%
|
(48)
-15%
|
(59)
-22%
|
(66)
-12%
|
(70)
-7%
|
(74)
-6%
|
(80)
-7%
|
(84)
-6%
|
(90)
-7%
|
(99)
-10%
|
(102)
-3%
|
(107)
-5%
|
(116)
-8%
|
(145)
-25%
|
(160)
-10%
|
(187)
-17%
|
(240)
-28%
|
(233)
+3%
|
(240)
-3%
|
(232)
+3%
|
(196)
+16%
|
(200)
-2%
|
(201)
-1%
|
(202)
-1%
|
(192)
+5%
|
(183)
+5%
|
(176)
+4%
|
(166)
+5%
|
(166)
0%
|
(75)
+55%
|
(69)
+8%
|
(49)
+28%
|
(37)
+26%
|
|
EPS (Diluted) |
-17.61
N/A
|
-24.18
-37%
|
-1.85
+92%
|
-1.43
+23%
|
-1.65
-15%
|
-1.72
-4%
|
-1.97
-15%
|
-2.39
-21%
|
-2.54
-6%
|
-2.7
-6%
|
-2.8
-4%
|
-2.99
-7%
|
-3.15
-5%
|
-3.07
+3%
|
-2.94
+4%
|
-3.02
-3%
|
-3.09
-2%
|
-3.2
-4%
|
-3.98
-24%
|
-4.15
-4%
|
-4.76
-15%
|
-5.49
-15%
|
-5.15
+6%
|
-5.3
-3%
|
-5.11
+4%
|
-4.31
+16%
|
-4.38
-2%
|
-4.38
N/A
|
-4.4
0%
|
-4.18
+5%
|
-3.98
+5%
|
-3.82
+4%
|
-3.6
+6%
|
-3.59
+0%
|
-1.6
+55%
|
-1.45
+9%
|
-1.04
+28%
|
-0.76
+27%
|